Russia’s fast-track coronavirus vaccine draws outrage over safety

  title={Russia’s fast-track coronavirus vaccine draws outrage over safety},
  author={Ewen Callaway},
  pages={334 - 335}
The immunization is the first approved for widespread use but could be dangerous because it hasn’t been tested in large trials, say researchers. The immunization is the first approved for widespread use but could be dangerous because it hasn’t been tested in large trials, say researchers. Russian President Vladimir Putin receives a video report about registration of the tested and registered coronavirus vaccine 

Efforts towards a COVID-19 vaccine.

  • H. Brüssow
  • Political Science
    Environmental microbiology
  • 2020
An overview of vaccine candidates in development, including preclinical and clinical testing, and it also mentions some of the societal problems of vaccine acceptance.

SARS-CoV-2 Leading Vaccine Candidates: Progress and Development

Various vaccine strategies that include nucleic acid (mRNA and DNA), viral vector based, partial or complete genome based inactivated, and protein subunit vaccines are summarized.

Various vaccine platforms in the field of COVID-19

Various technologies employed in the field of COVID-19 vaccine are discussed, as well as potential barriers and recent developments in this field.

Platforms Exploited for SARS-CoV-2 Vaccine Development

This review describes the latest advances in the development of SARS-CoV-2 vaccines for humans, mainly focusing on the lead candidates in clinical trials, and seeks to provide both the advantages and the disadvantages of the leading platforms used in current vaccine development, based on past vaccine delivery efforts for non-SARS CoV- 2 infections.

The Current Status of COVID-19 Vaccines

Evaluation of immune responses in a small number of individuals has demonstrated similar or superior levels of neutralizing antibodies in comparison to immunogenicity detected in COVID-19 patients.

The Fast Approval and Slow Rollout of Sputnik V: Why Is Russia’s Vaccine Rollout Slower than That of Other Nations?

The emergence of the SARS-CoV-2 pandemic in the beginning of 2020 led to the deployment of enormous amounts of resources by different countries for vaccine development, and the Russian Federation was

Biopharmaceuticals for prevention of COVID-19: A scoping review

This review summarizes major advances using biopharmaceuticals in the treatment and prevention strategies against COVID-19 that have occurred in the global medicinal system from its introduction until March 2022.

COVID-19 Vaccination Strategy in China: A Case Study

The coronavirus disease pandemic is under control in China through non-pharmaceutical interventions, and the mass vaccination program has been launched to further prevent the disease and progressed steadily with 483.34 million doses being administered across the country by 21 May 2021.

An Appraisal of the Current Scenario in Vaccine Research for COVID-19

This review is aimed at providing the current scenario and future perspectives in the development of vaccines against SARS-CoV-2, and identifying its genomic sequence and the presenting antigen.

A Review of the Progress and Challenges of Developing a Vaccine for COVID-19

This review will focus on the eight vaccine candidates that entered Phase 1 clinical trials in mid-May, including AstraZeneca/Oxford's AZD1222, Moderna's mRNA-1273 and Sinovac's CoronaVac vaccines, which are currently in advanced stages of vaccine development.